Persistent high factor VIII activity leading to increased thrombin generation - A prospective cohort study

Thrombosis Research

Volumn 129, Issue 4, 2012, Pages 447-452

  Ryland, J K ^a   Lawrie, A S ^a   MacKie, I J ^a   MacHin, S J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

D dimer; Factor VIII; FVIII; pathophysiology; thrombin generation; venous thrombosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; BILIRUBIN; BLOOD CLOTTING FACTOR 8; C REACTIVE PROTEIN; CREATININE; D DIMER; THROMBIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING PARAMETERS; BLOOD SAMPLING; CALIBRATED AUTOMATED THROMBOGRAM; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ETHNICITY; FEMALE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RISK ASSESSMENT; THROMBIN TIME; VENOUS THROMBOEMBOLISM;

ADULT; AGED; ANTICOAGULANTS; BIOLOGICAL MARKERS; COHORT STUDIES; FACTOR VIII; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; THROMBIN; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 84858342116     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.07.020     Document Type: Article

References (35)

1. I. Bank, E.J. Libourel, S. Middeldorp, K. Hamulyak, E.C. van Pampus, and M.M. Koopman Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis J Thromb Haemost 3 1 2005 79 84
2. P.W. Kamphuisen, R. Lensen, J.J. Houwing-Duistermaat, J.C. Eikenboom, M. Harvey, and R.M. Bertina Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia Br J Haematol 109 3 2000 519 522
3. T. Koster, A.D. Blann, E. Briet, J.P. Vandenbroucke, and F.R. Rosendaal Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis Lancet 345 8943 1995 152 155
4. J. O'Donnell, and M. Laffan Elevated plasma factor VIII levels-a novel risk factor for venous thromboembolism Clin Lab 47 1-2 2001 1 6
5. P.A. Kyrle, E. Minar, M. Hirschl, C. Bialonczyk, M. Stain, and B. Schneider High plasma levels of factor VIII and the risk of recurrent venous thromboembolism N Engl J Med 343 7 2000 457 462
6. J. O'Donnell, E.G. Tuddenham, R. Manning, G. Kemball-Cook, D. Johnson, and M. Laffan High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction Thromb Haemost 77 5 1997 825 828
7. J. O'Donnell, A.D. Mumford, R.A. Manning, and M. Laffan Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase response Thromb Haemost 83 1 2000 10 13
8. G.D. Lowe, F. Haverkate, S.G. Thompson, R.M. Turner, R.M. Bertina, and A.G. Turpie Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables: the ECAT DVT Study. European Concerted Action on Thrombosis Thromb Haemost 81 6 1999 879 886
9. E.P. Mansvelt, M. Laffan, J.H. McVey, and E.G. Tuddenham Analysis of the F8 gene in individuals with high plasma factor VIII:C levels and associated venous thrombosis Thromb Haemost 80 4 1998 561 565
10. K.R. Viel, D.K. Machiah, D.M. Warren, M. Khachidze, A. Buil, and K. Fernstrom A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels Blood 109 9 2007 3713 3724
11. J. O'Donnell, A.D. Mumford, R.A. Manning, and M.A. Laffan Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism Br J Haematol 115 3 2001 687 691
12. K.C. Jones, and K.G. Mann A model for the tissue factor pathway to thrombin. II. A mathematical simulation J Biol Chem 269 37 1994 23367 23373
13. S. Butenas, C. van 't Veer, K. Cawthern, K.E. Brummel, and K.G. Mann Models of blood coagulation Blood Coagul Fibrinolysis 11 Suppl. 1 2000 S9 S13
14. P.A. Kyrle, and S. Eichinger The risk of recurrent venous thromboembolism: the Austrian Study on Recurrent Venous Thromboembolism Wien Klin Wochenschr 115 13-14 2003 471 474
15. Vlieg A. van Hylckama, S.C. Christiansen, R. Luddington, S.C. Cannegieter, F.R. Rosendaal, and T.P. Baglin Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence Br J Haematol 138 6 2007 769 774
16. A. Tripodi, C. Legnani, G. Palareti, V. Chantarangkul, and P.M. Mannucci More on: high thrombin generation and the risk of recurrent venous thromboembolism J Thromb Haemost 7 5 2009 906 907
17. S. Eichinger, E. Minar, C. Bialonczyk, M. Hirschl, P. Quehenberger, and B. Schneider D-dimer levels and risk of recurrent venous thromboembolism JAMA 290 8 2003 1071 1074
18. G. Palareti, B. Cosmi, C. Legnani, A. Tosetto, C. Brusi, and A. Iorio D-dimer testing to determine the duration of anticoagulation therapy N Engl J Med 355 17 2006 1780 1789
19. G. Palareti, C. Legnani, B. Cosmi, G. Guazzaloca, C. Pancani, and S. Coccheri Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped Thromb Haemost 87 1 2002 7 12
20. S. Shrivastava, P.M. Ridker, R.J. Glynn, S.Z. Goldhaber, S. Moll, and H. Bounameaux D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism J Thromb Haemost 4 6 2006 1208 1214
21. M. Besser, C. Baglin, R. Luddington, Vlieg A. van Hylckama, and T. Baglin High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study J Thromb Haemost 6 10 2008 1720 1725
22. T.P. Baglin, D.M. Keeling, and H.G. Watson Guidelines on oral anticoagulation (warfarin): third edition-2005 update Br J Haematol 132 3 2006 277 285
23. R. Luddington, and T. Baglin Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition J Thromb Haemost 2 11 2004 1954 1959
24. H.C. Hemker, P. Giesen, R. al Dieri, V. Regnault, E. de Smedt, and R. Wagenvoord Calibrated automated thrombin generation measurement in clotting plasma Pathophysiol Haemost Thromb 33 1 2003 4 15
25. H.M. Spronk, A.W. Dielis, E. De Smedt, R. van Oerle, D. Fens, and M.H. Prins Assessment of thrombin generation II: Validation of the Calibrated Automated Thrombogram in platelet-poor plasma in a clinical laboratory Thromb Haemost 100 2 2008 362 364
26. H.M. Spronk, A.W. Dielis, M. Panova-Noeva, R. van Oerle, J.W. Govers-Riemslag, and K. Hamulyak Monitoring thrombin generation: is addition of corn trypsin inhibitor needed? Thromb Haemost 101 6 2009 1156 1162
27. J.K. Ryland, A.S. Lawrie, S.J. Machin, and I.J. Mackie Thrombin generation: the effect of pre-analytical variables on the calibrated automated thrombogram Br J Haematol 141 Supplement 1 2008 Abstract Number 216
28. J.K. Ryland, A.S. Lawrie, S.J. Machin, and I.J. Mackie Thrombin generation: corn trypsin inhibitor changes relationships between normal and thrombotic samples J Thromb Haemost 7 Supplement 2 2009 Abstract PP-WE-125
29. J.K. Ryland, A.S. Lawrie, S.J. Machin, and I.J. Mackie A comparative assessment of two thrombin generation assays in the analysis of samples from post-thrombotic patients Platelet 19 Supplement 1 2008 Abstract P25
30. L. Cristina, C. Benilde, C. Michela, F. Mirella, G. Giuliana, and P. Gualtiero High plasma levels of factor VIII and risk of recurrence of venous thromboembolism Br J Haematol 124 4 2004 504 510
31. R.A. Kraaijenhagen, P.S. in't Anker, M.M. Koopman, P.H. Reitsma, M.H. Prins, and E.A. van den High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism Thromb Haemost 83 1 2000 5 9
32. A.J. ten Cate-Hoek, A.W. Dielis, H.M. Spronk, R. van Oerle, K. Hamulyak, and M.H. Prins Thrombin generation in patients after acute deep-vein thrombosis Thromb Haemost 100 2 2008 240 245
33. M.G. Conlan, A.R. Folsom, A. Finch, C.E. Davis, P. Sorlie, and G. Marcucci Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study Thromb Haemost 70 3 1993 380 385
34. M. Cushman, D. Yanez, B.M. Psaty, L.P. Fried, G. Heiss, and M. Lee Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly: the Cardiovascular Health Study. Cardiovascular Health Study Investigators Am J Epidemiol 143 7 1996 665 676
35. P.E. Morange, D.A. Tregouet, C. Frere, N. Saut, L. Pellegrina, and M.C. Alessi Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort Br J Haematol 128 1 2005 91 99